CD274 and breast carcinoma: A study from 2023 by Mohammed et al. aimed to determine the potential effects of boron derivatives, sodium pentaborate pentahydrate, and sodium perborate tetrahydrate on breast cancer cell lines, PD-1/PD-L1 expression, and activated T cells [152].